Found: 3
Select item for more details and to access through your institution.
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 12, p. 2784, doi. 10.1002/ijc.22198
- By:
- Publication type:
- Article
Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics.
- Published in:
- International Journal of Cancer, 2005, v. 115, n. 4, p. 528, doi. 10.1002/ijc.20770
- By:
- Publication type:
- Article
A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
- Published in:
- Oncogene, 2005, v. 24, n. 8, p. 1403, doi. 10.1038/sj.onc.1208309
- By:
- Publication type:
- Article